SOD1 and amyotrophic lateral sclerosis: The authors demonstrated that BBG administration, starting at a late pre-symptomatic phase of the disease, delays ALS onset and improves general conditions and motor performance in both male and female SOD1-G93A mice, although survival was not enhanced.